Dopaminergic pathway and primary visual cortex are involved in the freezing of gait in Parkinson’s disease: a PET-CT study

References

• Nutt JG, Bloem BR, Giladi N, Hallett M, Horak FB, Nieuwboer A. Freezing of gait: moving forward on a mysterious clinical phenomenon. Lancet Neurol. 2011;10:734–744. doi:10.1016/S1474-4422(11)70143-021777828
   PubMed Web of Science ®Google Scholar
• Espay AJ, Fasano A, van Nuenen BF, Payne MM, Snijders AH, Bloem BR. “On” state freezing of gait in Parkinson disease: a paradoxical levodopa-induced complication. Neurology. 2012;78:454–457. doi:10.1212/WNL.0b013e3182477ec022262741
   PubMed Web of Science ®Google Scholar
• Schaafsma JD, Balash Y, Gurevich T, Bartels AL, Hausdorff JM, Giladi N. Characterization of freezing of gait subtypes and the response of each to levodopa in Parkinson’sdisease. Eur J Neurol. 2003;10:391–398.12823491
   PubMed Web of Science ®Google Scholar
• Ambani LM, Van Woert MH. Start hesitation–a side effect of long-term levodopa therapy. N Engl J Med. 1973;288:1113–1115. doi:10.1056/NEJM1973052428821084697941
   PubMed Web of Science ®Google Scholar
• Gilat M, Lígia Silva de Lima A, Bloem BR, Shine JM, Nonnekes J, Lewis SJG. Freezing of gait: promising avenues for future treatment. Parkinsonism Relat Disord. 2018;52:7–16. doi:10.1016/j.parkreldis.2018.03.00929550375
   PubMed Web of Science ®Google Scholar
• Cucca A, Biagioni MC, Fleisher JE, et al. Freezing of gait in Parkinson’s disease: from pathophysiology to emerging therapies. Neurodegener Dis Manag. 2016;6:431–446. doi:10.2217/nmt-2016-001827599588
   PubMedGoogle Scholar
• Nieuwboer A, Giladi N. Characterizing freezing of gait in Parkinson’s disease: models of an episodic phenomenon. Mov Disord. 2013;28:1509–1519. doi:10.1002/mds.2568324132839
   PubMed Web of Science ®Google Scholar
• Bartels AL, Leenders KL. Brain imaging in patients with freezing of gait. Mov Disord. 2008;23(Suppl 2):S461–S467. doi:10.1002/mds.2191218668627
   PubMed Web of Science ®Google Scholar
• Park HK, Kim JS, Im KC, et al. Functional brain imaging in pure akinesia with gait freezing: [18F] FDG PET and [18F] FP-CIT PET analyses. Mov Disord. 2009;24:237–245. doi:10.1002/mds.2234718951539
   PubMed Web of Science ®Google Scholar
• Pikstra ARA, van der Hoorn A, Leenders KL, de Jong BM. Relation of 18-F-Dopa PET with hypokinesia-rigidity, tremor and freezing in Parkinson’s disease. Neuroimage Clin. 2016;11:68–72. doi:10.1016/j.nicl.2016.01.01026909330
   PubMed Web of Science ®Google Scholar
• Ouchi Y, Kanno T, Okada H, et al. Changes in dopamine availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson’s disease. Brain. 2001;124:784–792.11287377
   PubMed Web of Science ®Google Scholar
• Kilbourn MR, Sherman PS, Kuszpit K. In vivo measures of dopaminergic radioligands in the rat brain: equilibrium infusion studies. Synapse. 2002;43:188–194. doi:10.1002/syn.1003911793424
   PubMed Web of Science ®Google Scholar
• Kilbourn MR. Long-term reproducibility of in vivo measures of specific binding of radioligands in rat brain. Nucl Med Biol. 2004;31:591–595. doi:10.1016/j.nucmedbio.2004.02.00315219277
   PubMed Web of Science ®Google Scholar
• Perez-Lloret S, Negre-Pages L, Damier P, et al. Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease. JAMA Neurol. 2014;71:884–890. doi:10.1001/jamaneurol.2014.75324839938
   PubMed Web of Science ®Google Scholar
• Okuma Y. Freezing of gait and falls in Parkinson’s disease. J Parkinsons Dis. 2014;4:255–260. doi:10.3233/JPD-13028224577502
   PubMedGoogle Scholar
• Giladi N, McDermott MP, Fahn S, et al. Freezing of gait in PD: prospective assessment in the DATATOP cohort. Neurology. 2001;56:1712–1722.11425939
   PubMed Web of Science ®Google Scholar
• Macht M, Kaussner Y, Möller JC, et al. Predictors of freezing in Parkinson’s disease: a survey of 6,620 patients. Mov Disord. 2007;22:953–956. doi:10.1002/mds.2145817377927
   PubMed Web of Science ®Google Scholar
• Fasano A, Herman T, Tessitore A, Strafella AP, Bohnen NI. Neuroimaging of Freezing of Gait. J Parkinsons Dis. 2015;5:241–254. doi:10.3233/JPD-15053625757831
   PubMedGoogle Scholar
• Forsaa EB, Larsen JP, Wentzel-Larsen T, Alves G. A 12-year population-based study of freezing of gait in Parkinson’s disease. Parkinsonism Relat Disord. 2015;21:254–258. doi:10.1016/j.parkreldis.2014.12.02025603767
   PubMed Web of Science ®Google Scholar
• Amboni M, Stocchi F, Abbruzzese G, et al. Attar features of self-reported freezing of gait in Parkinson disease: the DEEP FOG study. Parkinsonism Relat Disord. 2015;21:644–649. doi:10.1016/j.parkreldis.2015.03.02825899545
   PubMed Web of Science ®Google Scholar
• Ou R, Wei Q, Cao B, et al. Predictors of freezing of gait in Chinese patients with Parkinson’s disease. Brain Behav. 2018;8(3):e00931. doi:10.1002/brb3.93129541542
   PubMed Web of Science ®Google Scholar
• Sun Q, Wang T, Jiang TF, et al. Clinical profile of Chinese long-term parkinson’s disease survivors with 10 years of disease duration and Beyond. Aging Dis. 2018;9:8–16. doi:10.14336/AD.2017.020429392077
   PubMed Web of Science ®Google Scholar
• Brooks DJ. Monitoring neuroprotection and restorative therapies in Parkinson’s disease with PET. J Neural Transm Suppl. 2000;(60):125–137.
   Google Scholar
• Dickson DW. Parkinson’s disease and parkinsonism: neuropathology. Cold Spring Harb Perspect Med. 2012;2(8):pii: a009258. doi:10.1101/cshperspect.a009258
   Web of Science ®Google Scholar
• Braak H, Del Tredici K. Neuropathological staging of brain pathology in sporadic parkinson’s disease: separating the wheat from the chaff. J Parkinsons Dis. 2017;7(s1):S71–S85. doi:10.3233/JPD-17900128282810
   PubMedGoogle Scholar
• Villalba RM, Smith Y. Loss and remodeling of striatal dendritic spines in Parkinson’s disease: from homeostasis to maladaptive plasticity? J Neural Transm (Vienna). 2018;125:431–447. doi:10.1007/s00702-017-1735-628540422
   PubMed Web of Science ®Google Scholar
• Beck G, Singh A, Papa SM. Dysregulation of striatal projection neurons in Parkinson’s disease. J Neural Transm (Vienna). 2018;125:449–460. doi:10.1007/s00702-017-1744-528620834
   PubMed Web of Science ®Google Scholar
• Barthel C, Nonnekes J, van Helvert M, et al. The laser shoes: A new ambulatory device to alleviate freezing of gait in Parkinson disease. Neurology. 2018;90:e164–e171. doi:10.1212/WNL.000000000000479529263221
   PubMed Web of Science ®Google Scholar
• Ginis P, Nackaerts E, Nieuwboer A, Heremans E. Cueing for people with Parkinson’s disease with freezing of gait: A narrative review of the state-of-the-art and novel perspectives. Ann Phys Rehabil Med. 2018;61:407–413. doi:10.1016/j.rehab.2017.08.00228890341
   PubMed Web of Science ®Google Scholar
• Dahodwala N, Siderowf A, Baumgarten M, Abrams A, Karlawish J. Screening questionnaires for parkinsonism: a systematic review. Parkinsonism Relat Disord. 2012;18:216–224. doi:10.1016/j.parkreldis.2011.09.00321930414
   PubMed Web of Science ®Google Scholar
• Gao R, Zhang G, Chen X, et al. CSF biomarkers and its associations with 18F-AV133 cerebral VMAT2 binding in parkinson’s disease-a preliminary report. PLoS One. 2016;11:e0164762. doi:10.1371/journal.pone.016476227764160
   PubMed Web of Science ®Google Scholar
• Alexander PK, Lie Y, Jones G, et al. Management impact of imaging brain vesicular monoamine transporter type 2 in clinically uncertain parkinsonian syndrome with 18F-AV133 and PET. J Nucl Med. 2017;58:1815–1820. doi:10.2967/jnumed.116.18901928490469
   PubMed Web of Science ®Google Scholar
• Xu SS, Alexander PK, Lie Y, et al. Diagnostic accuracy of imaging brain vesicular monoamine transporter type 2 (VMAT2) in clinically uncertain parkinsonian syndrome (CUPS): a 3-year follow-up study in community patients. BMJ Open. 2018;8:e025533. doi:10.1136/bmjopen-2018-025533
   Web of Science ®Google Scholar